USP22 and hepatocellular carcinoma: Upregulated DNL is a crucial feature of MAFLD and HCC development, with ubiquitin-specific protease 22 (USP22) recently identified as a key regulator of DNL in MAFLD HCC, with high USP22 expression associated with poor prognosis and overall survival [80].